Skip to main content

Articles

1193 result(s) for 'cancer' within Journal of Ovarian Research

Page 24 of 24

  2. Most cases of ovarian cancer are epithelial in origin and diagnosed at advanced stage when the cancer is widely disseminated in the peritoneal cavity. ... immunocompetent syngeneic mouse model of disseminated epi...

    Authors: Bridget A Quinn, Fang Xiao, Laura Bickel, Lainie Martin, Xiang Hua, Andres Klein-Szanto and Denise C Connolly
    Citation: Journal of Ovarian Research 2010 3:24
    Content type: Research Published on:

  4. New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as ... 1 (LRG1) in ...

    Authors: John D Andersen, Kristin LM Boylan, Ronald Jemmerson, Melissa A Geller, Benjamin Misemer, Katherine M Harrington, Starchild Weivoda, Bruce A Witthuhn, Peter Argenta, Rachel Isaksson Vogel and Amy PN Skubitz
    Citation: Journal of Ovarian Research 2010 3:21
    Content type: Research Published on:

  5. chA21 is a novel tumor-inhibitory antibody which recognized subdomain I of HER2 extracellular domain with an epitope distinct from other HER2 antibodies. Previously, we demonstrated that chA21 inhibits human o...

    Authors: Anli Zhang, Guodong Shen, Ting Zhao, Guihong Zhang, Jing Liu, Lihua Song, Wei Wei, Ling Bing, Zhengsheng Wu and Qiang Wu
    Citation: Journal of Ovarian Research 2010 3:20
    Content type: Research Published on:

  6. This review describes the use of polymer micelle nanotechnology based chemotherapies for ovarian cancer. While various chemotherapeutic agents can be utilized ... improve the survival rate of patients with ovaria...

    Authors: Murali M Yallapu, Meena Jaggi and Subhash C Chauhan
    Citation: Journal of Ovarian Research 2010 3:19
    Content type: Review Published on:

  7. In view of the recent association of Brn-3 transcription factors with neuroblastomas, cervical, breast, and prostate cancers we examined the expression of Brn-3a( ... ) was also evaluated in normal ovarian and cancer

    Authors: Nuzhat Ahmed, Ardian Latifi, Clyde B Riley, Jock K Findlay and Michael A Quinn
    Citation: Journal of Ovarian Research 2010 3:17
    Content type: Research Published on:

  8. Cisplatin is more often used to treat ovarian cancer (OvCa), which provides modest survival advantage ... therapeutic outcomes. We have shown that ovarian cancer cells express CC chemokine receptor-9 (CCR9...

    Authors: Erica L Johnson, Rajesh Singh, Crystal M Johnson-Holiday, William E Grizzle, Edward E Partridge, James W Lillard Jr and Shailesh Singh
    Citation: Journal of Ovarian Research 2010 3:15
    Content type: Research Published on:

  9. Altered androgen hormone homeostasis and androgen receptor (AR) activity have been implicated in ovarian carcinogenesis but the relationship between AR expression in ovarian cancer and clinical outcome remains un...

    Authors: Björn Nodin, Nooreldin Zendehrokh, Jenny Brändstedt, Elise Nilsson, Jonas Manjer, Donal J Brennan and Karin Jirström
    Citation: Journal of Ovarian Research 2010 3:14
    Content type: Research Published on:

  11. Mesenchymal Progenitor/Stem Cells (MSC) respond to homing cues providing an important mechanism to deliver therapeutics to sites of injury and tumors. This property has been confirmed by many investigators, ho...

    Authors: Svetlana Komarova, Justin Roth, Ronald Alvarez, David T Curiel and Larisa Pereboeva
    Citation: Journal of Ovarian Research 2010 3:12
    Content type: Research Published on:

  12. Chemo/radio-resistance is a major obstacle in treating advanced ovarian cancer. The efficacy of current treatments may be improved by increasing the sensitivity of cancer cells to chemo/radiation therapies. Curcu...

    Authors: Murali M Yallapu, Diane M Maher, Vasudha Sundram, Maria C Bell, Meena Jaggi and Subhash C Chauhan
    Citation: Journal of Ovarian Research 2010 3:11
    Content type: Research Published on:

  13. Noscapine, an alkaloid from Papaver somniferum..., widely used as an antitussive, is being clinically studied in the treatment of polycystic ovary syndrome (PCOS) and a few other cancers primarily because of its ...

    Authors: Anjali Priyadarshani, Krishna Chuttani, Gaurav Mittal and Aseem Bhatnagar
    Citation: Journal of Ovarian Research 2010 3:10
    Content type: Research Published on:

  15. Ovarian cancer is particularly insidious in nature. Its ability ... symptoms make it the seventh leading cause of cancer related deaths in women. Additionally, the ... resistance to widely accepted chemotherapy r...

    Authors: Jennifer AA Gubbels, Nick Claussen, Arvinder K Kapur, Joseph P Connor and Manish S Patankar
    Citation: Journal of Ovarian Research 2010 3:8
    Content type: Review Published on:

  17. Ovarian follicle development is a complex process. Paracrine interactions between somatic and germ cells are critical for normal follicular development and oocyte maturation. Studies have suggested that the he...

    Authors: Jin-Yi Jiang, Huiling Xiong, Mingju Cao, Xuhua Xia, Marc-Andre Sirard and Benjamin K Tsang
    Citation: Journal of Ovarian Research 2010 3:6
    Content type: Research Published on:

  18. Activation of bone morphogenetic protein (BMP)4 signalling in human ovarian cancer cells induces a number of phenotypic changes in vitro, including altered cell morphology, adhesion, motility and invasion, relati...

    Authors: Trevor G Shepherd, Michelle L Mujoomdar and Mark W Nachtigal
    Citation: Journal of Ovarian Research 2010 3:5
    Content type: Research Published on:

  19. The Foxl2 transcription factor is required for ovarian function during follicular development. The mechanism of Foxl2 regulation of this process has not been elucidated. Our approach to begin to understand Fox...

    Authors: Jean M Escudero, Jodi L Haller, Colin M Clay and Kenneth W Escudero
    Citation: Journal of Ovarian Research 2010 3:4
    Content type: Research Published on:

  20. Endometrioid carcinoma of the ovary is one of the most types of epithelial ovarian cancer associated to endometrioisis. Endometrioid tumors as well ... ) in the most common subtypes of ovarian cancer cells compar...

    Authors: Mamadou Keita, Paul Bessette, Manuella Pelmus, Youssef Ainmelk and Aziz Aris
    Citation: Journal of Ovarian Research 2010 3:3
    Content type: Research Published on:

  22. The production of ascites is a common complication of ovarian cancer. Ascites constitute a unique tumor microenvironment that ... this context, we recently showed that ovarian cancer ascites may protect tumor cel...

    Authors: Denis Lane, Isabelle Matte, Claudine Rancourt and Alain Piché
    Citation: Journal of Ovarian Research 2010 3:1
    Content type: Research Published on:

  23. Ovarian cancer is the most lethal gynecologic malignancy and ... is only 35% after diagnosis. Epithelial ovarian cancer is a highly metastatic disease characterized by ... and ascites. The death incidences from o...

    Authors: Subhash C Chauhan, Deepak Kumar and Meena Jaggi
    Citation: Journal of Ovarian Research 2009 2:21
    Content type: Review Published on:

  24. During ovulation, it has been shown that LH stimulus induces the expression of numerous genes via PKA, p38 MAPK, PI3K and ERK1/2 in cumulus cells and granulosa cells. Our recent study showed that EGF-like fact...

    Authors: Yasuhisa Yamashita, Mitsugu Hishinuma and Masayuki Shimada
    Citation: Journal of Ovarian Research 2009 2:20
    Content type: Research Published on:

  25. Tumours with high proportions of differentiated cells are considered to be of a lower grade to those containing high proportions of undifferentiated cells. This property may be linked to the differentiation pr...

    Authors: Michael F Gallagher, Richard J Flavin, Salah A Elbaruni, Jamie K McInerney, Paul C Smyth, Yvonne M Salley, Sebastian F Vencken, Sharon A O'Toole, Alexandros Laios, Mathia YC Lee, Karen Denning, Jinghuan Li, Sinead T Aherne, Kai Q Lao, Cara M Martin, Orla M Sheils…
    Citation: Journal of Ovarian Research 2009 2:19
    Content type: Research Published on:

  26. Ovarian cancer is the most lethal gynecologic malignancy. The ... overexpressed in many solid neoplasms, including ovarian cancers, and contributes to neoplastic transformation and drug...

    Authors: Nicole S Anderson, Leslie Turner, Sandra Livingston, Ren Chen, Santo V Nicosia and Patricia A Kruk
    Citation: Journal of Ovarian Research 2009 2:16
    Content type: Research Published on:

  28. Ovarian epithelial tumors are an hallmark of hereditary cancer syndromes which are related to the germ-line inheritance of cancer predisposing mutations in BRCA1 and BRCA2 genes. ... 2-related as compared to "spo...

    Authors: Pierosandro Tagliaferri, Monica Ventura, Francesco Baudi, Iole Cucinotto, Mariamena Arbitrio, Maria Teresa Di Martino and Pierfrancesco Tassone
    Citation: Journal of Ovarian Research 2009 2:14
    Content type: Review Published on:

  32. The ovarian tumor marker CA125 is expressed on human MUC16, a cell surface bound mucin that is also shed by proteolytic cleavage. Human MUC16 is overexpressed by ovarian cancer cells. MUC16 facilitates the bindin...

    Authors: Cara AR Goodell, Jennifer A Belisle, Jennifer AA Gubbels, Martine Migneault, Claudine Rancourt, Joseph Connor, Muthusamy Kunnimalaiyaan, Rachel Kravitz, Ward Tucker, Michael Zwick and Manish S Patankar
    Citation: Journal of Ovarian Research 2009 2:8
    Content type: Research Published on:

  33. The most frequently used molecular imaging technique is currently 18F-deoxy-glucose (FDG) positron emission tomography (PET). FDG-PET holds promise in the evaluation of recurrent or residual ovarian cancer when C...

    Authors: Yoshio Yoshida, Tetsuji Kurokawa, Tetuya Tsujikawa, Hidehiko Okazawa and Fumikazu Kotsuji
    Citation: Journal of Ovarian Research 2009 2:7
    Content type: Review Published on:

  34. There is growing acceptance that polycystic ovaries are an important marker of polycystic ovary syndrome (PCOS) despite significant variability when making the ultrasound diagnosis. To better understand the na...

    Authors: Marla E Lujan, Donna R Chizen, Andrew K Peppin, Anita Dhir and Roger A Pierson
    Citation: Journal of Ovarian Research 2009 2:6
    Content type: Research Published on:

  35. We previously observed the over-expression of BMP-2 in primary cultures of epithelial ovarian cancer (EOC) cells as compared to normal...1...]. Here we investigate the effect of BMP-2 on several parameters of ova...

    Authors: Cécile Le Page, Marie-Line Puiffe, Liliane Meunier, Magdalena Zietarska, Manon de Ladurantaye, Patricia N Tonin, Diane Provencher and Anne-Marie Mes-Masson
    Citation: Journal of Ovarian Research 2009 2:4
    Content type: Research Published on:

  37. Platinum-resistance (PR) continues to be a major problem in the management of epithelial ovarian cancer (EOC). Response to various chemotherapeutic agents ... the effect of chemotherapy in prostate and pancreatic...

    Authors: Leigh A Solomon, Shadan Ali, Sanjeev Banerjee, Adnan R Munkarah, Robert T Morris and Fazlul H Sarkar
    Citation: Journal of Ovarian Research 2008 1:9
    Content type: Research Published on:

  39. Pituitary tumor transforming gene (PTTG), also known as securin is an important gene involved in many biological functions including inhibition of sister chromatid separation, DNA repair, organ development, and e...

    Authors: Siva Kumar Panguluri, Casey Yeakel and Sham S Kakar
    Citation: Journal of Ovarian Research 2008 1:6
    Content type: Review Published on:

  40. Malnutrition is a significant problem in patients with ovarian cancer. The goal of this study was to ... Global Assessment (SGA) in patients with ovarian cancer treated in an integrative cancer treatment setting.

    Authors: Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Sadie L Dahlk and Christopher G Lis
    Citation: Journal of Ovarian Research 2008 1:5
    Content type: Research Published on:

  41. Emerging evidence suggests that the capacity of a tumor to grow and propagate is dependent on a small subset of cells within a tumor, termed cancer stem cells. In fact, cancer cells, like stem cells, can prolifer...

    Authors: Moorthy P Ponnusamy and Surinder K Batra
    Citation: Journal of Ovarian Research 2008 1:4
    Content type: Review Published on:

  42. Ovarian adenocarcinoma is not generally discovered in patients until there has been widespread intraperitoneal dissemination, which is why ovarian cancer is the deadliest gynecologic malignancy. Though incomplete...

    Authors: Daniel R Christie, Faheem M Shaikh, John A Lucas IV, John A Lucas III and Susan L Bellis
    Citation: Journal of Ovarian Research 2008 1:3
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us